{"transactions":[{"id":1093,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-02T21:39:24.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":1571,"price":3.0175,"value":4740.4925,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The reporting person is voluntarily reporting the acquisition of the common stock pursuant to the  Issuer's Employee Stock Purchase Plan (\"ESPP\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of common stock purchased through the ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":324910,"source":{"system":"sec-edgar","filing":"0001449439-26-000007","document":"wk-form4_1788385162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000144943926000007/wk-form4_1788385162.xml","form_type":"4"}},{"id":1092,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-02T21:39:24.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":20614,"price":7.2175,"value":148781.545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of\nRestricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":323339,"source":{"system":"sec-edgar","filing":"0001449439-26-000007","document":"wk-form4_1788385162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000144943926000007/wk-form4_1788385162.xml","form_type":"4"}},{"id":841511,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option(right to buy)","published_at":"2026-03-16T19:17:29.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":3.16,"value":158000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on February 21, 2027, and 1/48th of the total number of shares subject to the option vest at the end of each calendar month thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":60000,"derivative":{"exercise_price":3.16,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001449439-26-000005","document":"wk-form4_1773703046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000144943926000005/wk-form4_1773703046.xml","form_type":"4"}},{"id":841510,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T19:17:29.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":1511,"price":3.077,"value":4649.347,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock purchased through ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":343953,"source":{"system":"sec-edgar","filing":"0001449439-26-000005","document":"wk-form4_1773703046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000144943926000005/wk-form4_1773703046.xml","form_type":"4"}},{"id":841509,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T19:17:29.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":3.16,"value":237000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 21, 2026, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":342442,"source":{"system":"sec-edgar","filing":"0001449439-26-000005","document":"wk-form4_1773703046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000144943926000005/wk-form4_1773703046.xml","form_type":"4"}},{"id":881811,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-25T19:11:03.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":1584,"price":3.61,"value":5718.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":267442,"source":{"system":"sec-edgar","filing":"0001449439-26-000003","document":"wk-form4_1772064661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000144943926000003/wk-form4_1772064661.xml","form_type":"4"}},{"id":1047815,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T19:40:39.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":20466,"price":9.79,"value":200362.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":269026,"source":{"system":"sec-edgar","filing":"0001628280-25-041688","document":"wk-form4_1757029236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000162828025041688/wk-form4_1757029236.xml","form_type":"4"}},{"id":1245932,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option(right to buy)","published_at":"2025-02-25T20:59:29.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":3.58,"value":35800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on February 21, 2026, and 1/48th of the total number of shares subject to the option vest at the end of each calendar month thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":10000,"derivative":{"exercise_price":3.58,"expiration_date":"2035-02-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001274737-25-000011","document":"wk-form4_1740535163.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000127473725000011/wk-form4_1740535163.xml","form_type":"4"}},{"id":1245931,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-25T20:59:29.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 21, 2025, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":289492,"source":{"system":"sec-edgar","filing":"0001274737-25-000011","document":"wk-form4_1740535163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000127473725000011/wk-form4_1740535163.xml","form_type":"4"}},{"id":1358937,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-19T19:24:38.000Z","date":"2024-11-15","kind":"purchase","planned":false,"acquired":true,"shares":22298,"price":2.98,"value":66448.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.84 to $3.25, inclusive. The reporting person undertakes to provide Exagen Inc., any security holder of Exagen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4."}],"balance_after":274492,"source":{"system":"sec-edgar","filing":"0001274737-24-000096","document":"wk-form4_1732062271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000127473724000096/wk-form4_1732062271.xml","form_type":"4"}},{"id":1414264,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T22:00:25.000Z","date":"2024-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":6690,"price":1.91,"value":12777.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024."}],"balance_after":421608,"source":{"system":"sec-edgar","filing":"0000950170-24-104133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024104133/ownership.xml","form_type":"4"}},{"id":1415558,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-04T18:12:32.000Z","date":"2024-09-01","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of September 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":252194,"source":{"system":"sec-edgar","filing":"0001274737-24-000084","document":"wk-form4_1725484460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000127473724000084/wk-form4_1725484460.xml","form_type":"4"}},{"id":1429755,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-19T21:30:02.000Z","date":"2024-08-15","kind":"exercise","planned":false,"acquired":false,"shares":13157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and 1/16th of the RSUs vested on August 15, 2024. The remaining unvested RSUs will be forfeited due to the resignation of the Reporting Person effective as of August 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and 1/16th of the RSUs vested on August 15, 2024. The remaining unvested RSUs will be forfeited due to the resignation of the Reporting Person effective as of August 31, 2024."}],"balance_after":144738,"derivative":{"underlying":"Common Stock","underlying_shares":13157},"source":{"system":"sec-edgar","filing":"0000950170-24-098700","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024098700/ownership.xml","form_type":"4"}},{"id":1429754,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-19T21:30:02.000Z","date":"2024-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4695,"price":1.55,"value":7277.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on May 15, 2023,\nwhich grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 17, 2023."}],"balance_after":428298,"source":{"system":"sec-edgar","filing":"0000950170-24-098700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024098700/ownership.xml","form_type":"4"}},{"id":1429753,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-19T21:30:02.000Z","date":"2024-08-15","kind":"exercise","planned":false,"acquired":true,"shares":13157,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":432993,"source":{"system":"sec-edgar","filing":"0000950170-24-098700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024098700/ownership.xml","form_type":"4"}},{"id":1507435,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-21T21:35:36.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable as to 1/16th of the underlying shares on August 20, 2024, with the remaining shares vesting in equal quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":400000,"derivative":{"exercise_price":2.58,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000950170-24-063094","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024063094/ownership.xml","form_type":"4"}},{"id":1507434,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-21T21:35:36.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 1/16th of the RSUs on August 20, 2024, with the remaining RSUs vesting in equally quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":419836,"source":{"system":"sec-edgar","filing":"0000950170-24-063094","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024063094/ownership.xml","form_type":"4"}},{"id":1514613,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-17T01:07:06.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":52631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and the remaining RSUs will vest in twelve equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and the remaining RSUs will vest in twelve equal quarterly installments thereafter."}],"balance_after":157895,"derivative":{"underlying":"Common Stock","underlying_shares":52631},"source":{"system":"sec-edgar","filing":"0000950170-24-061315","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024061315/ownership.xml","form_type":"4"}},{"id":1514612,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-17T01:07:06.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":18779,"price":2.54,"value":47698.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on May 15, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 17, 2023."}],"balance_after":119836,"source":{"system":"sec-edgar","filing":"0000950170-24-061315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024061315/ownership.xml","form_type":"4"}},{"id":1514611,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-17T01:07:06.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":52631,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":138615,"source":{"system":"sec-edgar","filing":"0000950170-24-061315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024061315/ownership.xml","form_type":"4"}},{"id":1883030,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-22T22:49:54.000Z","date":"2023-05-19","kind":"purchase","planned":false,"acquired":true,"shares":42492,"price":2.2878,"value":97213.1976,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $2.23 to $2.32. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":85984,"source":{"system":"sec-edgar","filing":"0001162194-23-000030","document":"wf-form4_168479578184518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000030/wf-form4_168479578184518.xml","form_type":"4"}},{"id":1883029,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-22T22:49:54.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":43492,"price":2.2157,"value":96365.2244,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $2.14 to $2.28. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":43492,"source":{"system":"sec-edgar","filing":"0001162194-23-000030","document":"wf-form4_168479578184518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000030/wf-form4_168479578184518.xml","form_type":"4"}},{"id":1889636,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-18T01:10:29.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable as to 1/4th of the underlying shares on May 15, 2024, and as to an additional 1/48th of the total number of shares each month thereafter, subject to Mr. Black's continued service through the applicable vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.9,"expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001162194-23-000028","document":"wf-form4_168437220935635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000028/wf-form4_168437220935635.xml","form_type":"4"}},{"id":1889635,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-18T01:10:29.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":210526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vest as to 1/4 of the underlying shares on May 15, 2024, and as to an additional 1/16th of the total number of shares every three months thereafter, subject to Mr. Black's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vest as to 1/4 of the underlying shares on May 15, 2024, and as to an additional 1/16th of the total number of shares every three months thereafter, subject to Mr. Black's continued service through the applicable vesting date."}],"balance_after":210526,"derivative":{"underlying":"Common Stock","underlying_shares":210526},"source":{"system":"sec-edgar","filing":"0001162194-23-000028","document":"wf-form4_168437220935635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000028/wf-form4_168437220935635.xml","form_type":"4"}},{"id":1927895,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T19:54:28.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":120834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":3.95,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":120834},"source":{"system":"sec-edgar","filing":"0001251769-23-000022","document":"wf-form4_168065245438395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176923000022/wf-form4_168065245438395.xml","form_type":"4"}},{"id":1927894,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T19:54:28.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":8.69,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001251769-23-000022","document":"wf-form4_168065245438395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176923000022/wf-form4_168065245438395.xml","form_type":"4"}},{"id":1927893,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-04T19:54:28.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":335330,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the disposition of the reporting person's 103,750 shares of Issuer common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock, was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the disposition of the reporting person's 82,680 shares of Issuer PSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding performance restricted stock unit award granted under any Issuer Stock Plan that vests based on achievement of any performance condition and the passage of time (each, an \"Issuer PSU\"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer PSU (determined as if all performance conditions in the applicable award agreements relating to such Issuer PSU have been satisfied as of immediately prior to the Effective Time), less applicable taxes and authorized deductions."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 2,680 Issuer PSUs which were previously withheld in error by the Issuer in connection with the net settlement of the reporting person's Issuer PSUs."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects the disposition of the reporting person's 148,900 shares of Issuer RSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an \"Issuer RSU\"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer RSU, less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of the reporting person's 103,750 shares of Issuer common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock, was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the disposition of the reporting person's 82,680 shares of Issuer PSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding performance restricted stock unit award granted under any Issuer Stock Plan that vests based on achievement of any performance condition and the passage of time (each, an \"Issuer PSU\"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer PSU (determined as if all performance conditions in the applicable award agreements relating to such Issuer PSU have been satisfied as of immediately prior to the Effective Time), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of the reporting person's 148,900 shares of Issuer RSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an \"Issuer RSU\"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer RSU, less applicable taxes and authorized deductions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001251769-23-000022","document":"wf-form4_168065245438395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176923000022/wf-form4_168065245438395.xml","form_type":"4"}},{"id":2124347,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-04T18:22:21.000Z","date":"2022-11-04","kind":"tax_withholding","acquired":false,"shares":15060,"price":6.46,"value":97287.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is not a sale of shares by the Reporting Person in the open market. Instead, this represents shares that have been withheld by the Issuer to satisfy the Reporting Person's income tax and withholding obligation in connection with the vesting of the first tranche of previously reported performance-based vesting restricted stock units reported on the Form 4 dated August 11, 2021. This net settlement was approved by the Issuer's compensation committee."}],"balance_after":332650,"source":{"system":"sec-edgar","filing":"0001251769-22-000085","document":"wf-form4_166760052642987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176922000085/wf-form4_166760052642987.xml","form_type":"4"}},{"id":2193170,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-05T18:06:50.000Z","date":"2022-08-05","kind":"tax_withholding","acquired":false,"shares":6190,"price":6.46,"value":39987.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is not a sale of shares by the Reporting Person in the open market. Instead, this represents shares that have been withheld by the Issuer to satisfy the Reporting Person's income tax and withholding obligation in connection with the vesting of the previously reported time-based vesting restricted stock units reported on the Form 4 dated August 11, 2021. This net settlement was approved by the Issuer's compensation committee."}],"balance_after":347710,"source":{"system":"sec-edgar","filing":"0001251769-22-000074","document":"wf-form4_165973719247854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176922000074/wf-form4_165973719247854.xml","form_type":"4"}},{"id":2229889,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T21:18:24.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":120834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option shall vest as to 25% on the first anniversary of the grant date and the remainder will vest in equal monthly installments over the following three years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan."}],"balance_after":120834,"derivative":{"exercise_price":3.95,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":120834},"source":{"system":"sec-edgar","filing":"0001251769-22-000055","document":"wf-form4_165542868589457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176922000055/wf-form4_165542868589457.xml","form_type":"4"}},{"id":2229888,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-16T21:18:24.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":88900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of Restricted Stock Units (\"RSUs\"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock pursuant to the Issuer's 2017 Equity Incentive Plan (the \"Plan\"). The RSUs vest in equal annual installments over four years commencing on the grant date, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Plan."}],"balance_after":353900,"source":{"system":"sec-edgar","filing":"0001251769-22-000055","document":"wf-form4_165542868589457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176922000055/wf-form4_165542868589457.xml","form_type":"4"}},{"id":2365106,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-01T18:22:44.000Z","date":"2022-03-01","kind":"purchase","acquired":true,"shares":10000,"price":6.2,"value":62000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average price of shares purchased. Prices ranged between $5.80 - $6.30, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":265000,"source":{"system":"sec-edgar","filing":"0001251769-22-000020","document":"wf-form4_164617694654276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176922000020/wf-form4_164617694654276.xml","form_type":"4"}},{"id":2365105,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-01T18:22:44.000Z","date":"2022-02-28","kind":"purchase","acquired":true,"shares":15000,"price":5.66,"value":84900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average price of shares purchased. Prices ranged between $5.58 - $5.76, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":255000,"source":{"system":"sec-edgar","filing":"0001251769-22-000020","document":"wf-form4_164617694654276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176922000020/wf-form4_164617694654276.xml","form_type":"4"}},{"id":2365104,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-01T18:22:44.000Z","date":"2022-02-25","kind":"purchase","acquired":true,"shares":15000,"price":5.48,"value":82200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average price of shares purchased. Prices ranged between $5.40 - $5.50, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":240000,"source":{"system":"sec-edgar","filing":"0001251769-22-000020","document":"wf-form4_164617694654276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176922000020/wf-form4_164617694654276.xml","form_type":"4"}},{"id":2606802,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-11T20:25:18.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":150000,"price":8.69,"value":1303500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"The shares underlying the option shall vest as to 25% on the first anniversary of the effective date (August 3, 2021) and the remainder will vest in equal monthly installments over the following three years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the option shall vest as to 25% on the first anniversary of the effective date (August 3, 2021) and the remainder will vest in equal monthly installments over the following three years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan."}],"balance_after":150000,"derivative":{"exercise_price":8.69,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001251769-21-000103","document":"wf-form4_162872789954355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176921000103/wf-form4_162872789954355.xml","form_type":"4"}},{"id":2606801,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-11T20:25:18.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Represents the grant of RSUs. Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock. One quarter of the RSU grant will vest on the first anniversary of the effective date (August 3, 2021) and the remainder will vest in equal annual installments over the following three years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan. The RSU grant will be governed by the terms of the 2017 Equity Incentive Plan."}],"balance_after":225000,"source":{"system":"sec-edgar","filing":"0001251769-21-000103","document":"wf-form4_162872789954355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176921000103/wf-form4_162872789954355.xml","form_type":"4"}},{"id":2606800,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-11T20:25:18.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Represents the grant of Restricted Stock Units (\"RSU\"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock. One third of the RSU grant will vest upon the achievement of revenue for the trailing four quarters equal to each of $70 million, $90 million and $110 million, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan. The RSU grant will be governed by the terms of the 2017 Equity Incentive Plan."}],"balance_after":145000,"source":{"system":"sec-edgar","filing":"0001251769-21-000103","document":"wf-form4_162872789954355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176921000103/wf-form4_162872789954355.xml","form_type":"4"}},{"id":2606799,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-11T20:25:18.000Z","date":"2021-08-11","kind":"purchase","acquired":true,"shares":25000,"price":8.75,"value":218750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average price of shares purchased. Prices ranged between $8.40 - $9.00, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001251769-21-000103","document":"wf-form4_162872789954355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000125176921000103/wf-form4_162872789954355.xml","form_type":"4"}},{"id":2796815,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-03-10T21:14:17.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":7000,"price":16.69,"value":116830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019, as amended November 27, 2020, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of previously granted restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.12 to $17.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":620770,"source":{"system":"sec-edgar","filing":"0001179110-21-003246","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911021003246/edgar.xml","form_type":"4"}},{"id":2849970,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-02-18T10:51:29.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":25000,"price":16.28,"value":407000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019, as amended November 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":627770,"source":{"system":"sec-edgar","filing":"0001179110-21-001849","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911021001849/edgar.xml","form_type":"4"}},{"id":3058624,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2020-08-13T18:07:16.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":5000,"price":6.42,"value":32100.0,"ownership":{"direct":true},"balance_after":652770,"source":{"system":"sec-edgar","filing":"0001179110-20-009015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911020009015/edgar.xml","form_type":"4"}},{"id":3065829,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2020-08-06T18:20:50.000Z","date":"2020-08-04","kind":"sale","acquired":false,"shares":8929,"price":5.03,"value":44912.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019 to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of previously granted restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.96 to $5.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":657770,"source":{"system":"sec-edgar","filing":"0001179110-20-008785","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911020008785/edgar.xml","form_type":"4"}},{"id":3147167,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2020-05-15T18:37:40.000Z","date":"2020-05-14","kind":"tax_withholding","acquired":false,"shares":23774,"price":4.06,"value":96522.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units."}],"balance_after":666699,"source":{"system":"sec-edgar","filing":"0001179110-20-006120","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911020006120/edgar.xml","form_type":"4"}},{"id":3170126,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2020-04-24T21:28:44.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":179178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On April 22, 2020, issuer granted to the reporting person 179,178 restricted stock units (RSUs), subject to receipt of required approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by at least such number as is necessary to vest all of the awards granted on April 22, 2020. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date; provided, however, that the vesting of 50% of these RSUs is subject to the additional condition that the publicly-traded stock price for the issuer's common stock reaches a 30-day average trading price equal to or above $7.52 per share during the first three years following the grant date. Should the publicly-traded stock price for the issuer's common stock reach a 30-day average trading price at or above $7.52 per share at any time during such three year period, this pricing condition will be satisfied and will terminate."},{"field":"date","element":"transactionDate","label":"F2","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"On April 22, 2020, issuer granted to the reporting person 179,178 restricted stock units (RSUs), subject to receipt of required approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by at least such number as is necessary to vest all of the awards granted on April 22, 2020. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date; provided, however, that the vesting of 50% of these RSUs is subject to the additional condition that the publicly-traded stock price for the issuer's common stock reaches a 30-day average trading price equal to or above $7.52 per share during the first three years following the grant date. Should the publicly-traded stock price for the issuer's common stock reach a 30-day average trading price at or above $7.52 per share at any time during such three year period, this pricing condition will be satisfied and will terminate."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 22, 2020, issuer granted to the reporting person 179,178 restricted stock units (RSUs), subject to receipt of required approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by at least such number as is necessary to vest all of the awards granted on April 22, 2020. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date; provided, however, that the vesting of 50% of these RSUs is subject to the additional condition that the publicly-traded stock price for the issuer's common stock reaches a 30-day average trading price equal to or above $7.52 per share during the first three years following the grant date. Should the publicly-traded stock price for the issuer's common stock reach a 30-day average trading price at or above $7.52 per share at any time during such three year period, this pricing condition will be satisfied and will terminate."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":690473,"source":{"system":"sec-edgar","filing":"0001179110-20-005125","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911020005125/edgar.xml","form_type":"4"}},{"id":3179785,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2020-04-08T16:01:13.000Z","date":"2020-04-06","kind":"grant","acquired":true,"shares":5996,"price":3.93,"value":23564.28,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On April 6, 2020, the restricted stock units (RSUs) were granted to the reporting person in connection with the reporting person's election to participate in the issuer's employee salary conversion plan, which was adopted by the Compensation Committee of the issuer's board of directors on April 1, 2020 in response to the novel coronavirus (COVID-19) and the financial impact on the issuer resulting therefrom. Under the terms of the plan, the reporting person is being granted RSUs in lieu of a percentage of the reporting person's cash compensation for the period between April 6, 2020 and July 10, 2020."},{"field":"date","element":"transactionDate","label":"F2","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs vest in full on July 10, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"On April 6, 2020, the restricted stock units (RSUs) were granted to the reporting person in connection with the reporting person's election to participate in the issuer's employee salary conversion plan, which was adopted by the Compensation Committee of the issuer's board of directors on April 1, 2020 in response to the novel coronavirus (COVID-19) and the financial impact on the issuer resulting therefrom. Under the terms of the plan, the reporting person is being granted RSUs in lieu of a percentage of the reporting person's cash compensation for the period between April 6, 2020 and July 10, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs vest in full on July 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The conversion price (cash for equity) is based on a 30-day volume weighted average price of the issuer's common stock as of close of market on Friday, April 3, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 6, 2020, the restricted stock units (RSUs) were granted to the reporting person in connection with the reporting person's election to participate in the issuer's employee salary conversion plan, which was adopted by the Compensation Committee of the issuer's board of directors on April 1, 2020 in response to the novel coronavirus (COVID-19) and the financial impact on the issuer resulting therefrom. Under the terms of the plan, the reporting person is being granted RSUs in lieu of a percentage of the reporting person's cash compensation for the period between April 6, 2020 and July 10, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs vest in full on July 10, 2020."}],"balance_after":511295,"source":{"system":"sec-edgar","filing":"0001179110-20-004798","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911020004798/edgar.xml","form_type":"4"}},{"id":3213437,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2020-03-12T12:55:34.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":6563,"price":5.075,"value":33307.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019 to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of previously granted restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":505299,"source":{"system":"sec-edgar","filing":"0001179110-20-003537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911020003537/edgar.xml","form_type":"4"}},{"id":3449130,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-08-02T21:01:48.000Z","date":"2019-08-02","kind":"sale","acquired":false,"shares":8929,"price":4.745,"value":42368.105,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019 to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of previously granted restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.66 to $4.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":511862,"source":{"system":"sec-edgar","filing":"0001179110-19-009056","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911019009056/edgar.xml","form_type":"4"}},{"id":3525958,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-05-15T20:13:36.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":68750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On May 13, 2019, issuer granted to the reporting person 68,750 restricted stock units, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 4,000,000 shares. The restricted stock units vest on the fourth anniversary of grant date; provided, however, that no portion of such restricted stock units shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such fourth anniversary date is equal to or greater than $6.18 per share (representing a 50% increase in the price per share as of the grant date)."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 13, 2019, issuer granted to the reporting person 68,750 restricted stock units, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 4,000,000 shares. The restricted stock units vest on the fourth anniversary of grant date; provided, however, that no portion of such restricted stock units shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such fourth anniversary date is equal to or greater than $6.18 per share (representing a 50% increase in the price per share as of the grant date)."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 13, 2019, issuer granted to the reporting person 68,750 restricted stock units, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 4,000,000 shares. The restricted stock units vest on the fourth anniversary of grant date; provided, however, that no portion of such restricted stock units shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such fourth anniversary date is equal to or greater than $6.18 per share (representing a 50% increase in the price per share as of the grant date)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."}],"balance_after":520791,"source":{"system":"sec-edgar","filing":"0001179110-19-006131","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911019006131/edgar.xml","form_type":"4"}},{"id":3525957,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-05-15T20:13:36.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On May 13, 2019, issuer granted to the reporting person 275,000 restricted stock units, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 4,000,000 shares. The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date; provided, however, that no portion of the restricted stock units shall vest at any time during the first four years following the grant date unless and until the publicly-traded stock price for the issuer's common stock reaches a 30-day average trading price equal to or above $5.36 per share (representing a 30% increase in the price per share as of the grant date). Should the publicly traded stock price for the issuer's common stock reach a 30-day average trading price at or above $5.36 per share, this pricing condition on the vesting of the restricted stock units shall be satisfied, and shall terminate."},{"field":"shares","element":"transactionShares","label":"F1","text":"On May 13, 2019, issuer granted to the reporting person 275,000 restricted stock units, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 4,000,000 shares. The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date; provided, however, that no portion of the restricted stock units shall vest at any time during the first four years following the grant date unless and until the publicly-traded stock price for the issuer's common stock reaches a 30-day average trading price equal to or above $5.36 per share (representing a 30% increase in the price per share as of the grant date). Should the publicly traded stock price for the issuer's common stock reach a 30-day average trading price at or above $5.36 per share, this pricing condition on the vesting of the restricted stock units shall be satisfied, and shall terminate."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 13, 2019, issuer granted to the reporting person 275,000 restricted stock units, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 4,000,000 shares. The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date; provided, however, that no portion of the restricted stock units shall vest at any time during the first four years following the grant date unless and until the publicly-traded stock price for the issuer's common stock reaches a 30-day average trading price equal to or above $5.36 per share (representing a 30% increase in the price per share as of the grant date). Should the publicly traded stock price for the issuer's common stock reach a 30-day average trading price at or above $5.36 per share, this pricing condition on the vesting of the restricted stock units shall be satisfied, and shall terminate."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."}],"balance_after":452041,"source":{"system":"sec-edgar","filing":"0001179110-19-006131","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911019006131/edgar.xml","form_type":"4"}},{"id":3856768,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-01T20:31:59.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":148445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest 25% on the first anniversary of the grant date and thereafter in 36 equal monthly installments; provided, however, that no portion of the option shall be exercisable at any time during the first four years following the grant date unless and until the publicly-traded stock price for the securities underlying the option reaches a 30-day average trading price equal to or above $4.20 per share. Should the publicly-traded stock price for the securities underlying the option reach a 30-day average trading price at or above $4.20 per share, this pricing condition on the exercise of the option shall be satisfied, and shall terminate."}],"balance_after":148445,"derivative":{"exercise_price":2.69,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Common Stock","underlying_shares":148445},"source":{"system":"sec-edgar","filing":"0001179110-18-010079","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911018010079/edgar.xml","form_type":"4"}},{"id":3856767,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2018-08-01T20:31:59.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":102041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On July 30, 2018, issuer granted to the reporting person 102,041 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date."},{"field":"shares","element":"transactionShares","label":"F1","text":"On July 30, 2018, issuer granted to the reporting person 102,041 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On July 30, 2018, issuer granted to the reporting person 102,041 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date."}],"balance_after":177041,"source":{"system":"sec-edgar","filing":"0001179110-18-010079","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911018010079/edgar.xml","form_type":"4"}},{"id":3923972,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-05-21T18:59:45.000Z","date":"2018-05-17","kind":"exercise","acquired":false,"shares":50,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Due to a rounding error, Reporting Person's Form 4 filing dated March 12, 2018 incorrectly stated that the number of shares of common stock underlying the Series B Convertible Preferred Stock purchased by Reporting Person on March 8, 2018 was 15,873.  The actual number of underlying shares was 15,874, which is reflected in this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15874},"source":{"system":"sec-edgar","filing":"0001179110-18-007275","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911018007275/edgar.xml","form_type":"4"}},{"id":3923971,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2018-05-21T18:59:45.000Z","date":"2018-05-17","kind":"exercise","acquired":true,"shares":15874,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Due to a rounding error, Reporting Person's Form 4 filing dated March 12, 2018 incorrectly stated that the number of shares of common stock underlying the Series B Convertible Preferred Stock purchased by Reporting Person on March 8, 2018 was 15,873.  The actual number of underlying shares was 15,874, which is reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion."}],"balance_after":49874,"source":{"system":"sec-edgar","filing":"0001179110-18-007275","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911018007275/edgar.xml","form_type":"4"}},{"id":4000975,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Warrants (right to buy)","published_at":"2018-03-12T18:11:03.000Z","date":"2018-03-08","kind":"grant","acquired":true,"shares":13492,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained."}],"balance_after":13492,"derivative":{"exercise_price":3.5,"underlying":"Common Stock","underlying_shares":13492},"source":{"system":"sec-edgar","filing":"0001179110-18-004080","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911018004080/edgar.xml","form_type":"4"}},{"id":4000974,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-03-12T18:11:03.000Z","date":"2018-03-08","kind":"grant","acquired":true,"shares":50,"price":1000,"value":50000.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained."}],"balance_after":50,"derivative":{"underlying":"Common Stock","underlying_shares":15873},"source":{"system":"sec-edgar","filing":"0001179110-18-004080","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911018004080/edgar.xml","form_type":"4"}},{"id":4230681,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2017-08-17T16:36:41.000Z","date":"2017-08-17","kind":"purchase","acquired":true,"shares":5000,"price":1.8,"value":9000.0,"ownership":{"direct":false,"nature":"by IRA"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person's Form 4 filing dated August 16, 2017, for purchase of 4,000 shares of common stock, incorrectly specified the Ownership Form of those shares as \"Direct.\"  The correct Ownership Form of those shares should have been labeled \"Indirect,\" with the Nature of the Beneficial Ownership being identified as \"by IRA.\"  For purposes of Item 5 of this Form 4, those 4,000 shares of common stock purchased on August 16 have been moved from \"Direct\" to \"Indirect\" as the correct Ownership Form."}],"balance_after":34000,"source":{"system":"sec-edgar","filing":"0001179110-17-011620","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911017011620/edgar.xml","form_type":"4"}},{"id":4232366,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2017-08-16T17:40:17.000Z","date":"2017-08-16","kind":"purchase","acquired":true,"shares":4000,"price":1.75,"value":7000.0,"ownership":{"direct":true},"balance_after":79000,"source":{"system":"sec-edgar","filing":"0001179110-17-011547","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911017011547/edgar.xml","form_type":"4"}},{"id":4250012,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-07-27T19:16:31.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":193000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over four years with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting in 36 installments every month for the three years thereafter; provided, however, that no portion of the option shall be exercisable at any time unless and until the publicly-traded stock price for the securities underlying the option reaches a 30-day average trading price equal to or above $3.00 per share.  Should the publicly-traded stock price for the securities underlying the option reach a 30-day average trading price at or above $3.00 per share, this pricing condition on the exercise of the option shall be satisfied, and shall terminate."}],"balance_after":193000,"derivative":{"exercise_price":1.68,"exercise_date":"2018-07-26","expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":193000},"source":{"system":"sec-edgar","filing":"0001179110-17-010752","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911017010752/edgar.xml","form_type":"4"}},{"id":4257136,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-07-14T12:43:10.000Z","date":"2017-07-14","kind":"exercise","acquired":false,"shares":50,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by IRA"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the Issuer's common stock following the date that shareholders approve such conversion, which approval was obtained on June 15, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the Issuer's common stock following the date that shareholders approve such conversion, which approval was obtained on June 15, 2017."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-17-010369","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911017010369/edgar.xml","form_type":"4"}},{"id":4257135,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2017-07-14T12:43:10.000Z","date":"2017-07-14","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by IRA"},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001179110-17-010369","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000117911017010369/edgar.xml","form_type":"4"}},{"id":4366894,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Warrants (right to  buy)","published_at":"2017-03-31T16:39:51.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by IRA"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained."}],"balance_after":25000,"derivative":{"exercise_price":2,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-17-009011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000089924317009011/doc4.xml","form_type":"4"}},{"id":4366893,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-03-31T16:39:51.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":50,"price":1000,"value":50000.0,"ownership":{"direct":false,"nature":"by IRA"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained."}],"balance_after":50,"derivative":{"exercise_price":2,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-17-009011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000089924317009011/doc4.xml","form_type":"4"}},{"id":4366892,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock - Restricted Stock Units","published_at":"2017-03-31T16:39:51.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock units (\"RSUs\") vest annually within 25% vesting on the anniversary of the grant date, and 25% vesting each anniversary thereafter."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0000899243-17-009011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000089924317009011/doc4.xml","form_type":"4"}},{"id":4384382,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":936,"kind":"person","name":"Black Jeffrey G.","position":1,"cik":"0001449439","reported_name":"Black Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-15T20:20:38.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over four years with 25% vesting on the anniversary of the grant date and the remaining 75% vesting in 36 installments every month for the three years thereafter."}],"balance_after":75000,"derivative":{"exercise_price":4.1,"expiration_date":"2027-03-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-17-007671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449439/000089924317007671/doc4.xml","form_type":"4"}}]}